BRPI0413324A - receptores de paladar hetero-oligoméricos t1r, linhas de células que expressam os ditos receptores, e compostos de paladar - Google Patents

receptores de paladar hetero-oligoméricos t1r, linhas de células que expressam os ditos receptores, e compostos de paladar

Info

Publication number
BRPI0413324A
BRPI0413324A BRPI0413324-2A BRPI0413324A BRPI0413324A BR PI0413324 A BRPI0413324 A BR PI0413324A BR PI0413324 A BRPI0413324 A BR PI0413324A BR PI0413324 A BRPI0413324 A BR PI0413324A
Authority
BR
Brazil
Prior art keywords
receptors
compounds
taste
cell lines
hetero
Prior art date
Application number
BRPI0413324-2A
Other languages
English (en)
Inventor
Xiaodong Li
Lena Staszewzki
Hong Xu
Original Assignee
Senomyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senomyx Inc filed Critical Senomyx Inc
Publication of BRPI0413324A publication Critical patent/BRPI0413324A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/56—Flavouring or bittering agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/202—Aliphatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/203—Alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/205—Heterocyclic compounds
    • A23L27/2054—Heterocyclic compounds having nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/88—Taste or flavour enhancing agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Seasonings (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"RECEPTORES DE PALADAR HETERO-OLIGOMéRICOS T1R, LINHAS DE CéLULAS QUE EXPRESSAM OS DITOS RECEPTORES, E COMPOSTOS DE PALADAR". A invenção se refere a compostos que se ligam especificamente a receptores ou fragmentos ou subunidades T1R1/T1R3 ou T1R2/T1R3. A presente invenção se refere ainda ao uso de receptores de paladar hetero-oligoméricos e quiméricos compreendendo o T1R1/T1R3 e o T1R2/T1R3 em ensaios para identificar compostos que respectivamente respondem ao estímulo de paladar umami e ao estímulo de paladar doce. Além disso, a invenção se refere ainda ao componente constitutivo de linhas de células que de maneira estável ou transitoriamente co-expressam a combinação de T1R1 e T1R3; ou T1R2 e T1R3; sob condições constitutivas ou indizíveis, A utilização destas linhas de células, em baseados em células para identificar compostos moduladores de paladar umami e doce, também é proporcionada particularmente através de ensaios de high throughput screening (também conhecida como HTS ou triagem de alto débito) que detectam a atividade de receptores pelo uso de imaging fluorimétrico.
BRPI0413324-2A 2003-08-06 2004-08-06 receptores de paladar hetero-oligoméricos t1r, linhas de células que expressam os ditos receptores, e compostos de paladar BRPI0413324A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49407103P 2003-08-06 2003-08-06
US55206404P 2004-03-09 2004-03-09
PCT/US2004/025459 WO2005015158A2 (en) 2003-08-06 2004-08-06 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds

Publications (1)

Publication Number Publication Date
BRPI0413324A true BRPI0413324A (pt) 2006-10-10

Family

ID=34138798

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0413324-2A BRPI0413324A (pt) 2003-08-06 2004-08-06 receptores de paladar hetero-oligoméricos t1r, linhas de células que expressam os ditos receptores, e compostos de paladar
BRPI0413347-1A BRPI0413347A (pt) 2003-08-06 2004-08-06 novos sabores, modificadores de sabor, agentes de sabor, realçadores de sabor, agentes de sabor e/ou realçadores umami ou doces, e utilização correspondente

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0413347-1A BRPI0413347A (pt) 2003-08-06 2004-08-06 novos sabores, modificadores de sabor, agentes de sabor, realçadores de sabor, agentes de sabor e/ou realçadores umami ou doces, e utilização correspondente

Country Status (19)

Country Link
US (15) US7476399B2 (pt)
EP (3) EP3431464A3 (pt)
JP (4) JP2007512227A (pt)
CN (1) CN103275058B (pt)
AR (1) AR046078A1 (pt)
AU (3) AU2004263871B2 (pt)
BR (2) BRPI0413324A (pt)
CA (3) CA2900181C (pt)
CL (2) CL2004002015A1 (pt)
ES (1) ES2733577T3 (pt)
IL (3) IL173551A (pt)
MX (1) MXPA06001510A (pt)
MY (1) MY174572A (pt)
NZ (6) NZ545746A (pt)
PH (8) PH12015501666B1 (pt)
RU (3) RU2006106920A (pt)
SG (2) SG153714A1 (pt)
WO (2) WO2005015158A2 (pt)
ZA (1) ZA200601904B (pt)

Families Citing this family (259)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US20080244761A1 (en) 2001-03-07 2008-10-02 Senomyx, Inc. T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
US7309577B2 (en) 2001-03-07 2007-12-18 Senomyx, Inc. Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste
US7763431B1 (en) 2001-03-07 2010-07-27 Senomyx, Inc. Binding assays that use the T1R2/T1R3 (sweet) taste receptor to identify compounds that elicit or modulate sweet taste
US7301009B2 (en) 2001-06-26 2007-11-27 Senomyx, Inc. Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
US7368285B2 (en) * 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
US7794959B2 (en) * 2001-04-05 2010-09-14 Senomyx, Inc. Identification of bitter receptors for hydrolyzed soy protein
US10078087B2 (en) * 2001-05-01 2018-09-18 Senomyx, Inc. Assays and enhancers of the human delta ENaC sodium channel
DK2327985T3 (en) 2001-06-26 2016-09-05 Senomyx Inc H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
EP1483283A4 (en) 2002-03-13 2007-04-11 Signum Biosciences Inc MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
CN1842709A (zh) 2003-07-10 2006-10-04 塞诺米克斯公司 使用表达人的ENaC的卵母细胞的改进的电生理测定法和用于在使用膜电位报告染料的测定中提高ENaC增强子功效的PHENAMIL的用途
US7906627B2 (en) 2003-08-06 2011-03-15 Senomyx, Inc. Chimeric human sweet-umami and umami-sweet taste receptors
AR046078A1 (es) 2003-08-06 2005-11-23 Senomyx Inc Nuevos sabores, modificadores de sabores, sustancias gustativas, mejoradores de gusto, sustancias gustativas y/o mejoradoras del gusto umani o dulce y uso de los mismos.
CN100582089C (zh) 2003-11-21 2010-01-20 吉万奥丹股份有限公司 N-取代的对-薄荷烷甲酰胺
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US7427421B2 (en) * 2004-09-10 2008-09-23 International Flavors & Fragrances Inc. Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
US7541055B2 (en) * 2004-09-10 2009-06-02 International Flavors & Fragrances Inc. Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
GB0425661D0 (en) * 2004-11-23 2004-12-22 Givaudan Sa Organic compounds
WO2006068745A1 (en) 2004-12-22 2006-06-29 Cargill, Incorporated Methods for determining cellular response to stimuli
CA2601777A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1855548A2 (en) * 2005-02-04 2007-11-21 Senomyx, Inc. Molecules comprising linked organic moieties as flavor modifiers for comestibles compositions
JP4734346B2 (ja) * 2005-02-04 2011-07-27 セノミックス インコーポレイテッド 連結ヘテロアリール部分を含む化合物、ならびに食用組成物のための新規なうまみフレーバー改変剤、味物質および味覚増強剤としての使用
MX2007010576A (es) * 2005-03-24 2007-10-04 Givaudan Sa Compuestos refrescantes.
US7560465B2 (en) * 2005-03-31 2009-07-14 Richard Holschen Compositions and methods for delivery of caffeine
US7851006B2 (en) 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
US7851005B2 (en) 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
EP1901622B1 (en) * 2005-05-23 2014-07-16 Intercontinental Great Brands LLC Taste potentiator compositions and beverages containing same
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
EP2368442B1 (en) 2005-07-27 2014-12-17 Symrise AG Use of hesperetin for enhancing the sweet taste
EP3312194A1 (en) * 2005-10-20 2018-04-25 Senomyx, Inc. Cell lines expressing chimeric human sweet-umami and umami-sweet taste receptors
KR101219281B1 (ko) * 2005-10-31 2013-01-08 (주)아모레퍼시픽 젠티식산 유도체 화합물과 그 제조방법 및 이를 함유하는미백화장료 조성물
EP1965832A4 (en) * 2005-11-04 2010-08-04 Ajinomoto Kk PROMOTER OF THE GASTROINTESTINAL FUNCTION
EP2175273B1 (en) * 2005-11-09 2013-09-04 Ajinomoto Co., Inc. Kokumi-imparting agent
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
ES2597843T3 (es) * 2005-11-24 2017-01-23 Dompé Farmaceutici S.P.A. Derivados de (R)-arilalquilamino y composiciones farmacéuticas que los contienen
US8007849B2 (en) * 2005-12-14 2011-08-30 International Flavors & Fragrances Inc. Unsaturated cyclic and acyclic carbamates exhibiting taste and flavor enhancement effect in flavor compositions
WO2007121604A2 (en) * 2006-04-20 2007-11-01 Givaudan Sa Method relating to sweetness enhancement
JP2009533065A (ja) 2006-04-20 2009-09-17 ジボダン エス エー 味覚物質同定のための機能的方法
CN101426381A (zh) * 2006-04-21 2009-05-06 西诺米克斯公司 含有高效鲜味调料的可食用组合物及其制备方法
ES2640453T3 (es) * 2006-04-21 2017-11-03 Senomyx, Inc. Procesos para preparar composiciones saborizantes sólidas
US7964376B2 (en) 2006-06-19 2011-06-21 Givaudan Sa Chimeric proteins and their use in methods to screen for sweet taste modulators
WO2008013969A2 (en) * 2006-07-28 2008-01-31 Senomyx, Inc. IMPROVED CELL-BASED FLUORESCENT ASSAYS FOR IDENTIFYING ALPHA AND DELTA ENaC MODULATORS
MX2009001783A (es) * 2006-08-22 2009-02-25 Redpoint Bio Corp Compuestos heterociclicos como potenciadores de edulcorantes.
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8039233B2 (en) 2007-01-18 2011-10-18 Givaudan S.A. Nucleic acid sequences and their use in methods to identify umami modulatiors
EP1955601A1 (de) 2007-01-25 2008-08-13 Symrise GmbH & Co. KG Verwendung von Propenylphenylglycosiden zur Verstärkung süßer sensorischer Eindrücke
EP1977655B1 (de) 2007-03-29 2011-05-18 Symrise AG Aromakompositionen von Alkamiden mit Hesperetin und/oder 4-Hydroxydihydrochalkonen und deren Salzen zur Verstärkung süßer sensorischer Eindrücke
US8765207B2 (en) * 2007-04-10 2014-07-01 Paul Coles Fruit product containing sugar alcohol
DE502008000732D1 (de) * 2007-05-08 2010-07-15 Symrise Gmbh & Co Kg Substituierte Cyclopropancarbonsäure(3-methyl-cyclohexyl)amide als Geschmacksstoffe
WO2008143963A1 (en) * 2007-05-17 2008-11-27 Cortex Pharmaceuticals, Inc. Di-substituted amides for enhancing glutamatergic synaptic responses
US8709521B2 (en) * 2007-05-22 2014-04-29 The Coca-Cola Company Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles
AU2013202912B2 (en) * 2007-06-08 2016-10-27 Firmenich Incorporated Modulation of chemosensory receptors and ligands associated therewith
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
US7928111B2 (en) * 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
US20080305500A1 (en) * 2007-06-08 2008-12-11 Senomyx, Inc. Novel cell-based assays for identifying enhancers or inhibitors of t1r taste receptors (t1r2/t1r3 sweet) and umami (t1r1/t1r3 umami) taste receptors
US8633186B2 (en) 2007-06-08 2014-01-21 Senomyx Inc. Modulation of chemosensory receptors and ligands associated therewith
BRPI0813957A2 (pt) * 2007-06-29 2015-01-06 Sumitomo Chemical Co Agente de controle de doença de planta, e método de controle de doença de planta
EP2064959B1 (de) 2007-10-31 2012-07-25 Symrise AG Aromatische Neo-Menthylamide als Geschmacksstoffe
US20100311610A1 (en) * 2008-02-01 2010-12-09 Chromocell Corporation CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended)
TWI429404B (zh) 2008-03-03 2014-03-11 Senomyx Inc 異山梨醇衍生物及彼等作為風味改良劑、促味劑及促味增強劑之用途
AU2009239430B2 (en) 2008-04-21 2015-01-22 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
EP2135516B1 (de) 2008-06-13 2012-08-15 Symrise AG Neo-Menthylderivate als Geschmacksstoffe
WO2010014813A2 (en) 2008-07-31 2010-02-04 Senomyx, Inc. Compositions comrpising sweetness enhancers and methods of making them
ES2915065T3 (es) 2008-07-31 2022-06-20 Firmenich Incorporated Procedimientos para hacer potenciadores del sabor dulce
DE102008042421A1 (de) 2008-09-26 2010-04-01 Symrise Gmbh & Co. Kg Geranylaminderivate der Oxalsäure
KR101834574B1 (ko) * 2009-01-29 2018-03-05 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 Ｇ 단백질 커플링 수용체 활성화 측정
PL216572B1 (pl) * 2009-02-02 2014-04-30 Inst Chemii Organicznej Polska Akademia Nauk Związki enaminokarbonylowe i ich zastosowanie
RU2377823C1 (ru) * 2009-02-13 2010-01-10 Олег Иванович Квасенков Способ производства ароматизированного тописолнечно-персикового напитка
RU2377829C1 (ru) * 2009-02-27 2010-01-10 Олег Иванович Квасенков Способ производства кофейного напитка "ступинский"
DE102009002268A1 (de) 2009-04-07 2010-10-14 Leibniz-Institut Für Pflanzenbiochemie 4,4'-Dihydroxydeoxybenzoine und deren Verwendung als Geschmacksverbesserer
EP2253226B1 (de) 2009-05-15 2015-07-15 Leibniz-Institut für Pflanzenbiochemie (IPB) Verwendung von Hydroxyflavan-Derivaten zur Geschmacksmodifizierung
WO2011019654A1 (en) * 2009-08-10 2011-02-17 Stokely-Van Camp, Inc. Method for suspending a flavonoid in a beverage
US10624372B2 (en) 2009-08-28 2020-04-21 Symrise Ag Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type
ATE528997T1 (de) 2009-08-28 2011-11-15 Symrise Ag SÜßMITTELREDUZIERTE PRODUKTE, AROMAMISCHUNGEN DAFÜR SOWIE VERFAHREN ZUM HERSTELLEN SOLCHER PRODUKTE
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US20120245213A1 (en) * 2009-10-01 2012-09-27 Bedrich Mosinger Human type i taste receptor subunit 3 modulators and methods of using same
GB0917325D0 (en) 2009-10-02 2009-11-18 Givaudan Sa Flavour enhancement
DE102009046126A1 (de) 2009-10-28 2011-05-12 Symrise Ag Oral konsumierbare Zubereitung umfassend Wurzelextrakt aus Mondia whitei
JP5905187B2 (ja) * 2009-12-02 2016-04-20 国立大学法人 東京大学 甘味受容体発現コンストラクト、これを発現させた細胞体、及びその利用
JP2011116693A (ja) * 2009-12-02 2011-06-16 Univ Of Tokyo 甘味物質に対するヒト甘味受容体作用性甘味調節物質
AU2010331939B2 (en) * 2009-12-18 2013-10-03 Stokely-Van Camp, Inc. Protein recovery beverage
EP2353403B1 (de) 2010-02-01 2012-07-11 Symrise AG Verwendung von 1-(2,4-Dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-on
GB201001796D0 (en) * 2010-02-04 2010-03-24 Givaudan Sa Compounds
RU2605549C2 (ru) 2010-04-02 2016-12-20 Синомикс, Инк. Производные 3-карбокси-4-аминохинолина, полезные как модификаторы сладкого вкуса
CN105962259A (zh) * 2010-04-15 2016-09-28 卓莫赛尔公司 用于减小或消除苦味的化合物、组合物和方法
WO2012021837A2 (en) 2010-08-12 2012-02-16 Senomyx, Inc. Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2012054530A2 (en) * 2010-10-19 2012-04-26 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2012054526A2 (en) * 2010-10-19 2012-04-26 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
EP2629609A4 (en) * 2010-10-19 2014-08-27 Elcelyx Therapeutics Inc THERAPIES BASED ON CHEMOSOUS RECEPTOR LIGANDS
AU2011329233A1 (en) 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
CN103260434B (zh) * 2010-11-30 2016-08-10 荷兰联合利华有限公司 精制植物分离物和由此植物分离物生产功能性食品成分的方法
GB201103103D0 (en) 2011-02-23 2011-04-06 Givaudan Sa Organic compounds
JP5856288B2 (ja) 2011-04-29 2016-02-09 インターコンチネンタル グレート ブランズ エルエルシー 封入酸、封入酸の調製方法、および封入酸を含むチューインガム
ES2433004T3 (es) 2011-05-31 2013-12-05 Symrise Ag Amidas de ácido cinámico como sustancias saporíferas especiadas
EP2529633B1 (de) 2011-06-01 2014-08-06 Symrise AG Oral konsumierbare Zubereitungen umfassend bestimmte süß schmeckende Triterpene und Triterpenglycoside
CN102311352B (zh) * 2011-07-11 2013-10-16 上海应用技术学院 一种2-甲氧基-4-甲基苄胺的合成方法
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
AU2012295255B2 (en) * 2011-08-12 2016-04-21 Senomyx, Inc. Sweet flavor modifier
EP2570036B1 (de) 2011-09-15 2014-06-18 Symrise AG Verwendung bestimmter Neoflavonoide zur Verstärkung und/oder Erzeugung eines süßen sensorischen Eindruckes
GB201118481D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118497D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118480D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118486D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118479D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
WO2013135511A1 (en) 2012-03-12 2013-09-19 Imax Discovery Gmbh N-(2,4-dimethylpentan-3-yl)-methylbenzamides and their use as flavoring agents
WO2013143822A1 (en) 2012-03-26 2013-10-03 Imax Discovery Gmbh Adenosine as sweetness enhancer for certain sugars
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
BR112015002380B1 (pt) 2012-08-06 2021-09-28 Firmenich Incorporated Composto, composições ingeríveis, processos para aumentar o sabor doce de composição e formulação flavorizante concentrada
EP2737807B1 (de) * 2012-11-30 2017-04-05 Symrise AG Verwendung von stickstoffhaltigen Derivaten der Zimtsäure als Geschmacksstoffe
EP2742983B1 (en) 2012-12-11 2017-08-23 Symrise AG Method for isolating fragrance and flavour compounds
WO2014095564A1 (en) * 2012-12-21 2014-06-26 Firmenich Sa Taste-modifying combinations
JO3155B1 (ar) 2013-02-19 2017-09-20 Senomyx Inc معدِّل نكهة حلوة
EP2983507B1 (en) 2013-03-15 2020-04-22 Applied Food Biotechnology, Inc. Feline bitter taste receptors and methods
US9169311B2 (en) 2013-03-15 2015-10-27 Applied Food Biotechnology, Inc. Feline bitter taste receptors and methods
US9804157B1 (en) 2013-03-15 2017-10-31 Senomyx, Inc. Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives
EP3019034B1 (en) 2013-07-01 2018-10-31 Givaudan SA Organic compounds
EP2832233A1 (en) * 2013-07-30 2015-02-04 IMAX Discovery GmbH 1H-pyrrole-2,4-dicarbonyl-derivatives and their use as flavoring agents
EP2832234A1 (en) 2013-07-30 2015-02-04 IMAX Discovery GmbH Imidazo[1,2-a]pyridine-ylmethyl-derivatives and their use as flavoring agents
WO2015038112A1 (en) 2013-09-11 2015-03-19 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
RU2720237C2 (ru) 2013-11-18 2020-04-28 Форма Терапеутикс, Инк. Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
CN110627770A (zh) 2013-11-18 2019-12-31 福马疗法公司 作为bet溴域抑制剂的四氢喹啉组成物
BR112016011747B1 (pt) 2013-12-05 2020-11-24 Givaudan Sa Uso de um composto modificador de sabor, composiçao comestivel contendo o referido composto bem como metodo para conferir, intensificar ou modificar um sabor umami e/ou salgado em um produto comestivel
EP2883459B1 (de) 2013-12-16 2018-04-04 Symrise AG Zubereitungen zur oralen Aufnahme
EP2918270A1 (de) 2014-03-12 2015-09-16 Symrise AG Aromatische Alkensäurederivate zur Appetithemmung und Stimmungsaufhellung
CN105247395B (zh) * 2014-03-26 2018-09-14 Lg化学株式会社 制造含有局部漂白区域的偏光元件的方法、制造偏光元件辊的方法以及制造单片式偏光元件的方法
JP6755640B2 (ja) 2014-03-28 2020-09-16 味の素株式会社 甘味受容体キメラタンパク質及びその利用
MX369091B (es) * 2014-05-09 2019-10-29 Firmenich & Cie Solubilizacion de modulador y sabor dulce.
WO2016073251A1 (en) 2014-11-07 2016-05-12 Senomyx, Inc. Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers
EP3229611B1 (en) 2014-12-10 2025-03-26 Mars, Incorporated Compounds that modulate fatty acid receptor activity and pet food products containing the same
WO2016118882A1 (en) * 2015-01-23 2016-07-28 cP2 SCIENCE, INC. Fragrance and flavor compositions comprising neopentyl glycol diacetate
CN108473484B (zh) 2015-10-01 2021-06-29 弗门尼舍公司 可用作trpm8调节剂的化合物
CN108473528B (zh) 2015-10-29 2026-01-16 弗门尼舍公司 高强度甜味剂
CN108463120A (zh) * 2016-02-03 2018-08-28 弗门尼舍有限公司 酰胺化合物的溶液和分散液
SMT202100565T1 (it) 2016-09-21 2021-11-12 Celanese Int Corp Composizioni di acesulfame potassico e processi per la loro preparazione
EP3753930A1 (en) 2016-09-21 2020-12-23 Celanese International Corporation Acesulfame potassium compositions and processes for producing same
EP3744716A1 (en) 2016-09-21 2020-12-02 Celanese International Corporation Acesulfame potassium compositions and processes for producing same
HRP20192165T4 (hr) 2016-09-21 2025-07-18 Celanese International Corporation Acesulfam-kalij-pripravci i postupci njihove proizvodnje
CN106620144B (zh) * 2016-12-29 2020-01-24 姜富春 一种治疗慢性盆腔炎的中药制剂及其制备方法
SG11201910136RA (en) 2017-05-03 2019-11-28 Firmenich Incorporated Methods for making high intensity sweeteners
US20200277404A1 (en) * 2017-09-12 2020-09-03 Monell Chemical Senses Center Compositions and methods for regulation of immune cell activation and proliferation
EP3681866B1 (en) * 2017-09-13 2022-01-05 Syngenta Participations AG Microbiocidal quinoline (thio)carboxamide derivatives
JP7173980B2 (ja) 2017-10-23 2022-11-17 日本たばこ産業株式会社 Ｇタンパク質共役受容体若しくはそのサブユニットを発現するためのコンストラクト及びその利用
EP3823455B1 (de) 2018-07-16 2025-10-01 Symrise AG Zusammensetzung zur substitution von zucker in backwaren
BR112021002261A2 (pt) 2018-08-07 2021-05-04 Firmenich Incorporated 2,2-dióxidos de 4-amino-1h-benzo[c][1,2,6]tiadiazina 5-substituídos e formulações e usos dos mesmos
US11871772B2 (en) 2018-08-10 2024-01-16 Firmenich Incorporated Antagonists of T2R54 and compositions and uses thereof
MX2021001967A (es) * 2018-09-10 2021-04-28 Heineken Supply Chain Bv Cerveza de bajo alcohol con sabor a mosto reducido.
EP3860363A1 (en) 2018-11-07 2021-08-11 Firmenich Incorporated Methods for making high intensity sweeteners
MX2021005219A (es) 2018-11-07 2021-06-18 Firmenich Incorporated Metodos para hacer edulcorantes de alta intensidad.
WO2020147977A1 (de) 2019-01-18 2020-07-23 Symrise Ag Kombinationsmittel
EP3704954A1 (en) 2019-03-05 2020-09-09 Symrise AG Mixture comprising d-allulose and taste modifying compounds
WO2020193321A1 (en) 2019-03-28 2020-10-01 Firmenich Sa Flavor system
WO2020200916A1 (en) 2019-04-04 2020-10-08 Firmenich Sa Mogroside compounds and uses thereof
WO2020251928A1 (en) * 2019-06-12 2020-12-17 Corn Products Development, Inc. Compositions with sugar like characteristics
BR112021014587A2 (pt) 2019-06-28 2022-01-04 Firmenich & Cie Misturas de gordura, emulsões das mesmas e usos relacionados
US20220273012A1 (en) 2019-09-05 2022-09-01 Firmenich Sa Flavanone derivatives and their use as sweetness enhancers
JP7763164B2 (ja) 2019-09-30 2025-10-31 ジボダン エス エー 有機化合物におけるまたは関連する改善
CN113226058A (zh) 2019-11-11 2021-08-06 弗门尼舍有限公司 姜酚化合物及其作为风味改良剂的用途
ES3060382T3 (en) 2019-12-13 2026-03-26 Firmenich Incorporated Taste modifying compositions and uses thereof
WO2021118864A1 (en) 2019-12-13 2021-06-17 Firmenich Incorporated Taste modifying compositions and uses thereof
US20230000122A1 (en) 2019-12-18 2023-01-05 Firmenich Incorporated Taste modifying compositions and uses thereof
BR112022009552A2 (pt) 2019-12-18 2022-08-16 Firmenich Incorporated Composições de modificação de gosto e usos das mesmas
CN111170960B (zh) * 2020-01-17 2022-04-15 东莞波顿香料有限公司 肉香味化合物及其制备方法和香料添加剂
EP4048086A1 (en) * 2020-03-05 2022-08-31 Firmenich SA 11-oxo-cucurbitanes and their use as flavor modifiers
US20230148641A1 (en) 2020-03-31 2023-05-18 Firmenich Sa Flavor composition
EP4055006A1 (en) 2020-04-17 2022-09-14 Firmenich SA Amino acid derivatives and their use as flavor modifiers
BR112022016262A2 (pt) 2020-05-22 2022-10-25 Firmenich & Cie Composições para reduzir gosto salgado e uso das mesmas
US20240239771A1 (en) * 2020-05-29 2024-07-18 Taxis Pharmaceuticals, Inc. Bacterial efflux pump inhibitors
US20230157341A1 (en) 2020-06-03 2023-05-25 Firmenich Sa Compositions for reducing off tastes and uses thereof
EP4171266A1 (en) 2020-06-24 2023-05-03 Firmenich SA Sweetening compositions and uses thereof
JP2023533893A (ja) 2020-07-14 2023-08-07 フイルメニツヒ ソシエテ アノニム オーラルケア製品における望ましくない味覚ノートの減少
KR20230041722A (ko) * 2020-07-24 2023-03-24 피르메니히 인코포레이티드 막관통 영역 결합을 통한 감칠맛 증진
CN115697082A (zh) 2020-09-22 2023-02-03 弗门尼舍有限公司 不含水杨酸甲酯的鹿蹄草风味剂组合物
EP4228433A1 (en) 2020-10-13 2023-08-23 Firmenich SA Malonyl steviol glycosides and their comestible use
CN114468199A (zh) 2020-10-27 2022-05-13 弗门尼舍有限公司 共轭二炔及其作为风味改良剂的用途
JP2023550963A (ja) * 2020-11-24 2023-12-06 フィルメニッヒ インコーポレイテッド コク味の増強及び関連するスクリーニング方法
EP4175490A1 (en) 2020-11-29 2023-05-10 Firmenich SA Compositions that reduce peroxide off taste and uses thereof
WO2022136288A1 (en) 2020-12-23 2022-06-30 Firmenich Sa Uses of fat blends and emulsions thereof
JPWO2022138890A1 (pt) * 2020-12-25 2022-06-30
WO2022148540A1 (en) 2021-01-08 2022-07-14 Symrise Ag Novel compositions for sour taste balancing
ES3018421T3 (es) 2021-01-13 2025-05-16 Firmenich Incorporated Composiciones que potencian el efecto refrescante
WO2022155668A1 (en) 2021-01-15 2022-07-21 Firmenich Incorporated Sweetener compostions comprising siamenoside i and uses thereof
CN117098460A (zh) 2021-01-15 2023-11-21 弗门尼舍公司 包含罗汉果苷的甜味剂组合物及其用途
JP2024503101A (ja) 2021-01-15 2024-01-24 フィルメニッヒ インコーポレイテッド モグロシドを含む甘味料組成物およびその使用
WO2022171569A1 (en) 2021-02-10 2022-08-18 Firmenich Sa Fiber blends, sweetened fiber blends, and their comestible use
JP2024509300A (ja) 2021-03-09 2024-02-29 フイルメニツヒ ソシエテ アノニム ヒドロキシおよびメトキシ置換フラボンならびにそれらの使用
EP4258900A1 (en) 2021-03-09 2023-10-18 Firmenich SA Hydroxy- and methoxy-substituted flavonoids and their use
US20240099343A1 (en) 2021-04-06 2024-03-28 Firmenich Sa Use of gingerdiol compounds to enhance flavor
US20240156140A1 (en) 2021-04-26 2024-05-16 Firmenich Incorporated Amide compounds and their use as flavor modifiers
WO2022231918A1 (en) 2021-04-26 2022-11-03 Firmenich Incorporated Amide compounds and their use as flavor modifiers
CN117279520A (zh) * 2021-04-26 2023-12-22 弗门尼舍公司 酰胺化合物及其作为风味修饰剂的用途
US20250275560A1 (en) 2021-05-11 2025-09-04 Firmenich Sa Process of making gingerol compounds and their use as flavor modifiers
US20240215596A1 (en) 2021-05-24 2024-07-04 Firmenich Sa Flavored fiber blends and their comestible use
JP2024522284A (ja) 2021-05-28 2024-06-13 フィルメニッヒ インコーポレイテッド 清涼効果を増強する組成物
WO2022253681A1 (en) 2021-06-02 2022-12-08 Firmenich Sa Deacetylation process, compositions, and uses thereof
JP2024524266A (ja) 2021-06-23 2024-07-05 フイルメニツヒ ソシエテ アノニム ラクターゼを含むフレーバー修飾組成物
WO2023278394A1 (en) 2021-06-28 2023-01-05 Firmenich Incorporated Polycationic salts of phenolic compounds and uses thereof
US20240225066A1 (en) 2021-06-29 2024-07-11 Firmenich Incorporated Mogroside compounds and their comestible use
CN117651498A (zh) 2021-06-29 2024-03-05 弗门尼舍有限公司 甘草化合物及其作为风味修饰剂的用途
EP4362689A1 (en) 2021-09-27 2024-05-08 Firmenich SA Flavor compositions containing iron compounds and their use
JP2024534633A (ja) 2021-09-27 2024-09-20 フィルメニッヒ インコーポレイテッド 蒸留酒のフレーバーを変調するためのバニリルエーテルの使用
CN116058486A (zh) 2021-10-29 2023-05-05 味之素株式会社 麻辣味增强剂组合物和食品
JP2024539838A (ja) 2021-11-01 2024-10-31 フイルメニツヒ ソシエテ アノニム 栄養素および味調節剤を含む組成物
EP4404767A2 (en) * 2021-11-16 2024-07-31 Firmenich Incorporated Amide compounds and their use as flavor modifiers
US20250052739A1 (en) 2021-12-07 2025-02-13 Firmenich Incorporated Reduction of bitter taste of plant proteins and related assays and screening methods
WO2023118002A1 (en) 2021-12-20 2023-06-29 Firmenich Sa Encapsulated metal compounds and comestible uses thereof
MX2024006776A (es) 2021-12-23 2024-06-20 Firmenich & Cie Composicion antimicrobiana que tiene colorante encapsulado.
CN114264766B (zh) * 2021-12-31 2022-08-16 江苏艾兰得营养品有限公司 一种vc软糖用甜橙香精评价方法
EP4473004A1 (en) 2022-02-11 2024-12-11 Firmenich Incorporated Cells expressing umami taste receptors and uses thereof
WO2023172415A1 (en) 2022-03-07 2023-09-14 Firmenich Incorporated Sweetener compositions
EP4448477A1 (en) 2022-03-10 2024-10-23 Firmenich SA Sweetener compositions
CN118843399A (zh) * 2022-03-11 2024-10-25 弗门尼舍公司 酰胺化合物及其作为风味修饰剂的用途
CN118829632A (zh) 2022-03-11 2024-10-22 弗门尼舍公司 黄烷酮化合物及其作为风味修饰剂的用途
EP4472442A1 (en) 2022-03-25 2024-12-11 Firmenich SA Fatty acid amides and their use as flavor modifiers
EP4460184A1 (en) 2022-03-28 2024-11-13 Firmenich SA Non-animal protein compositions and uses thereof
US20250204564A1 (en) 2022-04-06 2025-06-26 Firmenich Incorporated Taste modifying compositions and uses thereof
JP2025510598A (ja) 2022-04-11 2025-04-15 フイルメニツヒ ソシエテ アノニム 甘味料組成物
US20250275559A1 (en) 2022-05-16 2025-09-04 Firmenich Incorporated Saturated fatty acids and their use to modify taste
CN119212571A (zh) 2022-05-16 2024-12-27 弗门尼舍公司 不饱和脂肪酸及其修饰味道的用途
WO2023232968A1 (en) 2022-06-03 2023-12-07 Firmenich Sa Fat reduction in non-animal protein compositions
CA3257371A1 (en) 2022-06-14 2023-12-21 Firmenich Sa Polyelectrolyte Protein Complexes and Their Uses
CN119421642A (zh) 2022-06-24 2025-02-11 弗门尼舍有限公司 味道修饰组合物及其用途
EP4525821A1 (en) 2022-07-07 2025-03-26 Firmenich Incorporated Compositions that enhance the cooling effect
WO2024041974A1 (en) 2022-08-22 2024-02-29 Firmenich Sa Gel compositions and their use in seafood analogue products
WO2024089025A1 (en) 2022-10-26 2024-05-02 Firmenich Sa Extrusion methods and flavored products formed thereby
JP2026508065A (ja) 2022-10-26 2026-03-10 フィルメニッヒ インコーポレイテッド 味改変組成物およびその使用
CN120129464A (zh) 2022-10-27 2025-06-10 弗门尼舍有限公司 黄酮类化合物及其用途
EP4580420A1 (en) 2022-11-01 2025-07-09 Firmenich SA Low-calorie composition for flavor modification
EP4608172A1 (en) 2022-12-22 2025-09-03 Firmenich SA Natural sweetener compositions and uses thereof
CN120417784A (zh) 2022-12-22 2025-08-01 弗门尼舍有限公司 含烷基乳酸酯的天然甜味剂组合物及其用途
WO2024137186A1 (en) 2022-12-23 2024-06-27 Firmenich Incorporated Beta-cyclodextrin and its use to modify flavor
CN120513026A (zh) 2023-01-09 2025-08-19 弗门尼舍有限公司 植物纤维用于改善发酵产品风味的用途
WO2024170640A1 (en) 2023-02-15 2024-08-22 Firmenich Sa Thermoresponsive gel composition and uses thereof
CN120752224A (zh) 2023-02-25 2025-10-03 弗门尼舍公司 黄烷酮化合物及其作为风味修饰剂的用途
EP4683521A1 (en) 2023-03-23 2026-01-28 Firmenich Incorporated Use of vanillyl ethers to modify flavor
WO2024200171A1 (en) 2023-03-24 2024-10-03 Firmenich Sa Microparticles containing algal proteins and uses thereof
JP2026511252A (ja) 2023-03-28 2026-04-10 フイルメニツヒ ソシエテ アノニム 味改変組成物およびその使用
WO2024205979A1 (en) 2023-03-29 2024-10-03 Firmenich Incorporated Use of fatty acids to modify flavor
WO2024208837A1 (en) 2023-04-04 2024-10-10 Firmenich Sa Polysaccharide compositions and their comestible use
EP4704828A2 (en) * 2023-04-24 2026-03-11 Baylor College of Medicine Inhibitors of jun n-terminal kinases (jnk1, jnk2, and/or jnk3) and mitogen-activated protein kinases (mapk8, mapk9, and/or mapk10) and methods of using same
WO2024227789A1 (en) 2023-05-03 2024-11-07 Firmenich Sa Encapsulated phenolic compounds and their comestible use
GB202307621D0 (en) 2023-05-22 2023-07-05 Givaudan Sa Improvements in or relating to organic compounds
EP4680039A1 (en) 2023-06-09 2026-01-21 DSM-Firmenich AG Compositions for reducing off notes and uses thereof
EP4480319A1 (en) 2023-06-22 2024-12-25 DSM-Firmenich AG Granola cluster
WO2025067974A1 (en) 2023-09-26 2025-04-03 Firmenich Sa Vegan cheese compositions and methods of making the same
WO2025073683A1 (en) 2023-10-04 2025-04-10 Firmenich Sa Flavanone compounds and their use as flavor modifiers
WO2025125286A1 (en) 2023-12-13 2025-06-19 Firmenich Sa Biopolymer compositions and their use in foamed compositions
WO2025132821A1 (en) 2023-12-19 2025-06-26 Firmenich Sa Comestible products having high fiber and low sugar
WO2025132803A1 (en) 2023-12-20 2025-06-26 Firmenich Sa 3-hydroxybenzoic acid and its use as a flavor modifier
WO2025191050A1 (en) 2024-03-15 2025-09-18 Firmenich Sa Lipid particles and their comestible use
WO2025202256A1 (en) 2024-03-28 2025-10-02 Firmenich Sa Cooling composition
WO2025221883A1 (en) 2024-04-17 2025-10-23 Firmenich Incorporated Taste modifying compositions and uses thereof
WO2025230968A1 (en) 2024-04-30 2025-11-06 Firmenich Incorporated Ketone compounds for enhancing alcohol perception
WO2026064099A1 (en) 2024-09-17 2026-03-26 Firmenich Incorporated Dihydrochalcone compounds for enhancing alcohol perception
WO2026064098A1 (en) 2024-09-17 2026-03-26 Firmenich Incorporated Flavonoid compounds for enhancing alcohol perception
JP7854103B1 (ja) 2025-11-04 2026-04-30 小川香料株式会社 炭酸感増強剤

Family Cites Families (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987544A (en) 1961-06-06 Tranquilizers
US415052A (en) * 1889-11-12 And samuel j
BE418027A (pt) 1935-10-22
GB502680A (en) 1936-10-10 1939-03-21 Du Pont Improvements in or relating to the isolation of boron fluoride
US2510945A (en) * 1945-04-24 1950-06-13 Us Agriculture Nu-cyclohexyl nicotinamide
US2519408A (en) * 1946-10-09 1950-08-22 Schering Corp Antispasmodics
NL186845B (nl) * 1953-04-16 Thomas Dwight Creekmore Orthodontische beugel.
GB858333A (en) * 1956-10-05 1961-01-11 Unilever Ltd Flavouring substances and their preparation
US3098693A (en) 1960-05-27 1963-07-23 Little Inc A Treatment of protein and peptide materials to form amide linkages
US3492323A (en) * 1963-08-21 1970-01-27 Hoffmann La Roche N-(2-propynyloxy)-sulfanilamides
US3281330A (en) 1964-03-20 1966-10-25 Upjohn Co Microbiological process for the oxygenation of cycloalkanes
US3294544A (en) * 1964-11-06 1966-12-27 Richardson Merrell Inc Artificial sweetener-arabinogalactan composition and edible foodstuff utilizing same
GB1193289A (en) * 1965-07-14 1970-05-28 Science Union & Cie New Isoindolino-Sulphonylurea Derivatives and Process for Preparing them
NL129208C (pt) * 1965-07-14
NL131479C (pt) * 1966-04-20
US3400132A (en) * 1966-05-31 1968-09-03 Abbott Lab Tertiary 2, 6-dihalo-isonicotinamide derivatives
DE1695428C3 (de) * 1967-06-08 1978-10-05 Merck Patent Gmbh, 6100 Darmstadt Derivate des 5-Mercaptopyridoxins und Verfahren zu deren Herstellung
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
US4021224A (en) * 1971-12-09 1977-05-03 Stauffer Chemical Company Herbicide compositions
US4034109A (en) * 1973-01-18 1977-07-05 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4177279A (en) * 1973-10-10 1979-12-04 John Wyeth & Brother Ltd. 1-[(3-Indolyl)-alkyl]-piperidyl ureas and hypotensive compositions
JPS5329211Y2 (pt) 1973-10-15 1978-07-22
JPS5716973B2 (pt) 1973-10-17 1982-04-08
GB1457671A (en) 1974-01-31 1976-12-08 Wilkinson Sword Ltd Flavour
GB1489359A (en) * 1974-12-11 1977-10-19 Wilkinson Sword Ltd Alicyclic carboxamides having physiological cooling activity
US3944082A (en) 1974-12-20 1976-03-16 Harnischfeger Corporation Locking means for relatively movable boom sections of boom of mobile crane
JPS51106736A (ja) * 1975-03-14 1976-09-21 Rikagaku Kenkyusho Noengeiyosatsukinzai
US3988510A (en) * 1975-05-29 1976-10-26 International Flavors & Fragrances Inc. 3-Furyl sulfides and foodstuff flavor compositions comprising same
GB1502680A (en) 1975-06-03 1978-03-01 Wilkinson Sword Ltd Compositions for application to or consumption by the human body and containing compounds having a physiological cooling effect
JPS5825980B2 (ja) * 1976-02-12 1983-05-31 ヤマサ醤油株式会社 サイクリックヌクレオチドの定量法
US4049717A (en) * 1976-05-13 1977-09-20 American Cyanamid Company Novel 1,2,3,4-tetrahydro-4-oxo-(oxy)-1-naphthylamines and method of preparation thereof
US4332724A (en) * 1976-08-12 1982-06-01 American Cyanamid Co. Process for preparing 4,5,6,7-tetrahydro-7-oxobenzo[b]thiophenes and 1,2,3,4-tetrahydro-4-oxonaphthalenes
EP0005501B1 (de) 1978-05-20 1981-11-25 Bayer Ag Heteroaryl-oxyessigsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide
US4535084A (en) 1979-10-15 1985-08-13 Pfizer Inc. Certain 4-(2-hydroxyethylthiomethyl)pyridines and derivatives thereof having immunoregulatory activity
US4535081A (en) * 1979-11-23 1985-08-13 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0055689B1 (de) 1980-12-22 1984-07-04 Schering Aktiengesellschaft In 3-Stellung substituierte 2,4,6-trihalogenierte Benzamide und deren Salze, deren Herstellung und Verwendung als Ersatzstoffe für natürliche Süssstoffe sowie Süssungsmittel auf Basis dieser Verbindungen
US4517288A (en) * 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2533210A1 (fr) * 1982-09-17 1984-03-23 Lyon I Universite Claude Edulcorants de synthese
GB8309855D0 (en) * 1983-04-12 1983-05-18 Tate & Lyle Plc Flavour modifiers
US4571345A (en) * 1983-06-13 1986-02-18 Cumberland Packing Corp. 1,1-Diaminoalkane derived sweeteners
US5476849A (en) * 1984-03-19 1995-12-19 The Rockefeller University Methods for glycosylation inhibition using amino-benzoic acids and derivatives
FR2573087B1 (fr) * 1984-11-09 1987-07-10 Inst Francais Du Petrole Procede d'adoucissement des coupes petrolieres effectue en absence de compose alcalin
IL76842A0 (en) 1984-12-28 1986-02-28 Monsanto Co Novel n-acyl-n-isopropyl-glycine derivatives
JPS61200951A (ja) * 1985-03-01 1986-09-05 Kyowa Hakko Kogyo Co Ltd シクロペンタンカルボン酸誘導体
US5506337A (en) * 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JPS61200951U (pt) 1985-06-04 1986-12-16
JPS6181858A (ja) 1985-08-09 1986-04-25 Honda Motor Co Ltd 車両のアンチロック制動装置
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US4835181A (en) * 1987-02-18 1989-05-30 Eli Lilly And Company Anticonvulsant agents using cyano dimethylphenyl benzamides
JPH0784428B2 (ja) * 1987-10-19 1995-09-13 鐘淵化学工業株式会社 ジペプチド誘導体およびそれを含有する甘味剤
FR2624699B1 (fr) * 1987-12-18 1990-04-13 Bernard Lyon I Universite Clau Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-glycine ou beta-alanine utiles comme agents edulcorants
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5176928A (en) * 1988-08-04 1993-01-05 The Nutrasweet Company Reduced calorie diary mix
JPH02108697A (ja) * 1988-10-15 1990-04-20 Kanegafuchi Chem Ind Co Ltd ジペプチド誘導体及びそれを含有するペプチド甘味剤
US4910031A (en) 1988-12-19 1990-03-20 Frito-Lay, Inc. Topped savory snack foods
JPH02108697U (pt) 1989-02-17 1990-08-29
US5001115A (en) 1989-05-17 1991-03-19 University Of Florida Prodrugs of biologically active hydroxyaromatic compounds
DE3916430A1 (de) 1989-05-20 1990-11-22 Bayer Ag Verfahren zur herstellung von 3-amino-5-aminocarbonyl-1,2,4-triazol-derivaten
CA2020887A1 (en) 1989-07-28 1991-01-29 Michael Klaus Aromatic carboxylic amides
US5147463A (en) 1989-08-18 1992-09-15 Basf K&F Corporation Cyclic acetals
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5057601A (en) 1989-11-06 1991-10-15 Olin Corporation Process for producing a gel-free coagulated rubber with low ethylenic unsaturation
US5021249A (en) 1989-11-09 1991-06-04 Warner-Lambert Company Method of making a savory flavor granule and a free flowing savory flavor granule
ES2151463T5 (es) 1989-12-22 2012-10-29 Merck Serono Sa Constructos de ADN para la activación y la modificación de la expresión de genes endógenos
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
JPH04505546A (ja) 1990-02-09 1992-09-24 アスラブ　ソシエテ　アノニム 写真平版マイクロ製造法を用いて製造した放射場静電マイクロモーター及び前記マイクロモーターの製造方法
JP2933975B2 (ja) 1990-04-26 1999-08-16 長谷川香料株式会社 飲食品の甘味強化方法
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
MA22668A1 (fr) 1990-07-10 1993-07-01 Smithkline Beecham Corp Procede de preparation d'oxamides .
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5508407A (en) * 1991-07-10 1996-04-16 Eli Lilly And Company Retroviral protease inhibitors
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
PT101031B (pt) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
FR2684670B1 (fr) * 1991-12-05 1995-04-07 Commissariat Energie Atomique Amides a substituant heterocyclique azote, leur procede de preparation et leur utilisation pour extraire selectivement les actinides (iii) et les separer en particulier des lanthanides (iii).
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5283722A (en) 1992-08-05 1994-02-01 Koenen Howard P Surgical-type glove and illuminator assembly
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US6664107B1 (en) * 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
US5426039A (en) * 1993-09-08 1995-06-20 Bio-Rad Laboratories, Inc. Direct molecular cloning of primer extended DNA containing an alkane diol
US5547966A (en) 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
NZ270267A (en) * 1993-12-30 1997-03-24 Hoechst Ag 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions
DE69535315T2 (de) 1994-01-10 2007-06-28 Teva Pharmaceutical Industries Ltd. 1-aminoindanderivate und zusammensetzungen hiervon
US5914349A (en) * 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
US5519134A (en) * 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5593853A (en) * 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5522175A (en) 1994-06-01 1996-06-04 Biosource Technologies, Inc. Natural savory and umami flavoring materials from dehydrated mushroom
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) * 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
JPH08103243A (ja) * 1994-10-06 1996-04-23 T Hasegawa Co Ltd 持続性香気香味賦与剤
US6287620B1 (en) * 1994-10-07 2001-09-11 Firmenich Sa Flavor enhancing methods
US5801195A (en) 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
ZA96211B (en) 1995-01-12 1996-07-26 Teva Pharma Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
GB2299859B (en) 1995-04-10 1999-07-28 Otter Controls Ltd Thermally responsive steam sensor device
RU2156235C2 (ru) 1995-05-31 2000-09-20 Кумиай Кемикал Индастри Ко., Лтд. Производные фенилалканамида, способы их получения и сельскохозяйственный или садовый фунгицид
AU698739B2 (en) 1995-06-06 1998-11-05 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US5977322A (en) 1995-06-14 1999-11-02 The Regents Of The University Of California High affinity human antibodies to tumor antigens
US5985662A (en) 1995-07-13 1999-11-16 Isis Pharmaceuticals Inc. Antisense inhibition of hepatitis B virus replication
AU710838B2 (en) * 1995-07-26 1999-09-30 Firmenich S.A. Flavoured products and a process for their preparation
AU6777896A (en) * 1995-08-25 1997-03-19 E.I. Du Pont De Nemours And Company Bicyclic herbicides
US6133317A (en) 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate composition and method of treatment
WO1997029079A1 (en) 1996-02-06 1997-08-14 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
CA2278424A1 (en) * 1997-01-22 1998-07-23 Bret Eugene Huff Process for preparing indane-like compounds
AU723895B2 (en) 1997-01-29 2000-09-07 Pfizer Inc. Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
US6462148B1 (en) 1997-04-07 2002-10-08 Hitachi Chemical Co., Ltd. Adhesive film of quinoline polymer and bismaleimide
AR013079A1 (es) 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
MY119059A (en) 1997-08-11 2005-03-31 Cadbury Adams Usa Llc Enhanced flavoring compositions containing n-ethyl-p-menthane-3-carboxamide and method of making and using same
EP1034783B1 (en) * 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
US6429207B1 (en) * 1997-11-21 2002-08-06 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
CN1158264C (zh) 1997-11-21 2004-07-21 Nps药物有限公司 用于治疗中枢神经系统疾病的代谢性谷氨酸受体拮抗剂
US6432454B1 (en) 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
ES2196753T3 (es) 1998-01-05 2003-12-16 Arla Foods Amba Uso de d-tagatosa comosinergizador e intensificador del sabor.
DE19808261A1 (de) * 1998-02-27 1999-10-28 Bayer Ag Arylphenylsubstituierte cyclische Ketoenole
DE19818732A1 (de) * 1998-04-27 1999-10-28 Bayer Ag Arylphenylsubstituierte cyclische Ketoenole
WO1999059582A1 (en) * 1998-05-19 1999-11-25 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
DK1100811T3 (da) * 1998-07-28 2007-11-05 Univ California Nucleinsyrer, som koder for en G-protein-koblet receptor involveret i sensorisk transduktion
US7402400B2 (en) * 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
BR9912545A (pt) 1998-07-28 2001-10-30 Univ California ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
US6617351B1 (en) * 1998-07-31 2003-09-09 Eli Lilly And Company Amide, carbamate, and urea derivatives
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea
JP2000169438A (ja) 1998-10-02 2000-06-20 Kumiai Chem Ind Co Ltd アリ―ル酢酸アミド誘導体及び農園芸用殺菌剤
US6399731B2 (en) 1998-10-08 2002-06-04 The University Of Akron Chain transfer agents and its use in polymer synthesis
US7183278B1 (en) * 1998-11-04 2007-02-27 Meiji Seika Kaisha, Ltd. Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AUPP891299A0 (en) 1999-02-26 1999-03-25 Fujisawa Pharmaceutical Co., Ltd. New 6-membered cyclic compounds
US6362165B1 (en) * 1999-03-30 2002-03-26 Pharmacor Inc. Hydroxyphenyl derivatives with HIV integrase inhibitory properties
JP2000344752A (ja) * 1999-04-01 2000-12-12 Sumitomo Pharmaceut Co Ltd 点眼剤
TW593241B (en) 1999-04-20 2004-06-21 Hoffmann La Roche Carbamic acid derivatives
WO2000069283A1 (en) * 1999-05-13 2000-11-23 The Nutrasweet Company USE OF ADDITIVES TO MODIFY THE TASTE CHARACTERISTICS OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER
ES2546386T3 (es) * 1999-07-20 2015-09-23 Dow Agrosciences, Llc Amidas aromáticas heterocíclicas fungicidas y sus composiciones, métodos de uso y preparación
US6463445B1 (en) 1999-08-27 2002-10-08 Sony Electronics Inc. Multimedia information retrieval system and method including format conversion system and method
AU1607701A (en) 1999-11-15 2001-05-30 J. Manheimer, Inc. Flavor freshness enhancers
AU2001228811A1 (en) * 2000-01-26 2001-08-07 Ono Pharmaceutical Co. Ltd. Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
JP3587361B2 (ja) 2000-01-27 2004-11-10 キヤノン株式会社 有機発光素子
US20040121042A1 (en) * 2001-04-25 2004-06-24 Kabushiki Kaisha Yakult Honsha Fermented foods and process for producing the same
JP3112457B2 (ja) 2000-03-01 2000-11-27 曽田香料株式会社 甘味強化剤
TW201006846A (en) * 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
US6608176B2 (en) 2000-03-31 2003-08-19 University Of Miami Taste receptor for umami (monosodium glutamate) taste
EP1142490B1 (en) 2000-04-06 2006-08-16 Quest International B.V. Flavouring a foodstuff with compounds containing a sulphur atom linked to two specific atoms or groups
WO2001077292A2 (en) 2000-04-07 2001-10-18 Senomyx, Inc. Novel signal transduction molecules
AU5125801A (en) 2000-04-07 2001-10-23 Senomyx Inc T2r taste receptors and genes encoding same
DE10019145A1 (de) 2000-04-18 2001-10-25 Bayer Ag Phenylsubstituierte 4-Hydroxy-tetrahydropyridone
DE10021246A1 (de) 2000-04-25 2001-10-31 Schering Ag Substituierte Benzoesäureamide und deren Verwendung als Arzneimittel
AU2001281817B2 (en) 2000-06-21 2005-11-24 F. Hoffmann-La Roche Ag Benzothiazole derivatives
US7374878B2 (en) * 2000-06-22 2008-05-20 Senomyx, Inc. Receptor fingerprinting, sensory perception, and biosensors of chemical sensants
DE10030891A1 (de) * 2000-06-23 2002-01-03 Haarmann & Reimer Gmbh 3,4-Dihydroxybenzyl-substituierte Kohlensäurederivate und ihre Verwendung als Antioxidantien in kosmetischen und pharmazeutischen Präparaten
US6399641B1 (en) 2000-07-13 2002-06-04 Hoffmann-La Roche Inc. 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
US7041457B2 (en) * 2000-10-30 2006-05-09 Senomyx, Inc. Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
WO2002036622A2 (en) 2000-10-30 2002-05-10 Senomyx, Inc. GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS
US6365215B1 (en) 2000-11-09 2002-04-02 International Flavors & Fragrances Inc. Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof
JP3744791B2 (ja) 2000-12-01 2006-02-15 株式会社リコー トナーリサイクル装置およびそれを備える電子写真式画像形成装置
TW201022287A (en) * 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
JP2002234898A (ja) * 2001-02-08 2002-08-23 Ajinomoto Co Inc 新規ｎ−アルキルアスパルチルジペプチド誘導体及び甘味剤
US20040063742A1 (en) 2001-02-15 2004-04-01 Dan Peters Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
DE10109856A1 (de) * 2001-03-01 2002-09-05 Bayer Ag Arzneimittel gegen virale Erkrankungen
US6617249B2 (en) 2001-03-05 2003-09-09 Agilent Technologies, Inc. Method for making thin film bulk acoustic resonators (FBARS) with different frequencies on a single substrate and apparatus embodying the method
US6955887B2 (en) * 2001-03-30 2005-10-18 Senomyx, Inc. Use of T1R hetero-oligomeric taste receptor to screen for compounds that modulate taste signaling
US7301009B2 (en) * 2001-06-26 2007-11-27 Senomyx, Inc. Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
US7368285B2 (en) * 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
US7309577B2 (en) * 2001-03-07 2007-12-18 Senomyx, Inc. Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste
DE10117823A1 (de) 2001-04-10 2002-10-17 Merck Patent Gmbh Oxalsäurederivate
EP1252825A1 (en) 2001-04-25 2002-10-30 Société des Produits Nestlé S.A. Flavouring compositions
US20030089885A1 (en) * 2001-04-25 2003-05-15 Senomyx, Inc. Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids
AU2002308481A1 (en) * 2001-05-01 2002-11-11 Senomyx, Inc. High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
DK2327985T3 (en) * 2001-06-26 2016-09-05 Senomyx Inc H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
EP2293067B1 (en) 2001-06-26 2016-04-20 Senomyx, Inc. T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
WO2003004992A2 (en) * 2001-07-03 2003-01-16 The Regents Of The University Of California Mammalian sweet and amino acid heterodimeric taste receptors
IL159242A0 (en) * 2001-07-06 2004-06-01 Senomyx Inc Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
CN1610830A (zh) * 2001-07-10 2005-04-27 塞诺米克斯公司 特异性t2r味觉受体在鉴定阻断苦味觉的化合物中的应用
AU2002342607B2 (en) 2001-08-06 2006-10-19 Pharmacia Italia S.P.A. Aminoisoxazole derivatives active as kinase inhibitors
EP1291342A1 (en) * 2001-09-06 2003-03-12 Societe Des Produits Nestle S.A. Pyridinium-betain compounds as taste enhancer
UA76492C2 (en) * 2001-09-21 2006-08-15 Lilly Co Eli Muscarinic agonists, a pharmaceutical composition on their basis
JP4840837B2 (ja) * 2001-09-28 2011-12-21 日本たばこ産業株式会社 旨味を有する新規ペプチド、及びそれを旨味成分とする調味料
WO2003030937A1 (en) * 2001-10-05 2003-04-17 Ono Pharmaceutical Co., Ltd. Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
JP2005507932A (ja) 2001-10-12 2005-03-24 バイエル・フアーマシユーチカルズ・コーポレーシヨン 肥満の処置のためのフェニル置換５−員窒素含有複素環
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
CN1205175C (zh) * 2001-11-02 2005-06-08 中国人民解放军军事医学科学院毒物药物研究所 胺衍生物在制备具有抗肺动脉高压作用的药物中用途
US7329426B2 (en) 2001-11-13 2008-02-12 Applied Food Biotechnology, Inc. Treatment of vegetable oils or animal fats with sulfur or nitrogen donor compounds for animal food flavorings
EP1312268A1 (en) * 2001-11-19 2003-05-21 Société des Produits Nestlé S.A. Flavouring compositions
US7208290B2 (en) * 2001-12-14 2007-04-24 Senomyx, Inc. Methods of co-expressing umami taste receptors and chimeric Gα15 variants
US7344845B2 (en) * 2001-12-21 2008-03-18 Senomyx, Inc. Olfactory receptor for isovaleric acid and related malodorants and use thereof in assays for identification of blockers of malodor
EP1323356B1 (de) * 2001-12-27 2006-03-15 Symrise GmbH & Co. KG Verwendung von Ferulasäureamiden als Aromastoffe
US7057040B2 (en) 2002-02-07 2006-06-06 Council Of Scientific And Industrial Research Substituted aryl alkenoic acid heterocyclic amides
US6818772B2 (en) * 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
WO2003091217A1 (en) 2002-04-26 2003-11-06 Ishihara Sangyo Kaisha, Ltd. Pyridine compounds or salts thereof and herbicides containing the same
EP1512396A4 (en) * 2002-06-05 2008-12-31 Inst Med Molecular Design Inc HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT
US20040006135A1 (en) 2002-06-19 2004-01-08 Pfizer Inc. Combination treatment for depression and anxiety
IL165669A0 (en) * 2002-07-29 2006-01-15 Senomyx Inc Identification of a novel bitter taste receptor t2r76
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
US7635709B2 (en) * 2002-09-26 2009-12-22 The United States Of America As Represented By The Department Of Veterans Affairs Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
EP1603928B1 (en) 2003-03-10 2007-08-01 Nestec S.A. Pyridinium-betain compounds and their use
PL1633724T3 (pl) 2003-03-12 2011-10-31 Kudos Pharm Ltd Pochodne ftalazynonu
AU2004230923A1 (en) 2003-04-08 2004-10-28 Flexitral, Inc. Fragrance compositions comprising benzo(4,5)thieno(3,2-b)pyran-2-one
US20060094699A1 (en) * 2003-04-11 2006-05-04 Kampen Gita Camilla T Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
ATE482747T1 (de) 2003-04-11 2010-10-15 High Point Pharmaceuticals Llc Neue amide derivate und deren pharmazeutische verwendungen
DK1638941T3 (da) 2003-05-22 2010-10-11 Abbott Lab Indazol-, benzisoxazol- og benzisothiazolkinaseinhibitorer
AR046078A1 (es) 2003-08-06 2005-11-23 Senomyx Inc Nuevos sabores, modificadores de sabores, sustancias gustativas, mejoradores de gusto, sustancias gustativas y/o mejoradoras del gusto umani o dulce y uso de los mismos.
US20060045953A1 (en) 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US7191089B2 (en) 2004-12-01 2007-03-13 Freescale Semiconductor, Inc. System and method for fall detection
US7711312B2 (en) 2005-02-03 2010-05-04 Educational Testing Service Method and system for detecting off-topic essays without topic-specific training
JP4734346B2 (ja) 2005-02-04 2011-07-27 セノミックス インコーポレイテッド 連結ヘテロアリール部分を含む化合物、ならびに食用組成物のための新規なうまみフレーバー改変剤、味物質および味覚増強剤としての使用
EP1855548A2 (en) * 2005-02-04 2007-11-21 Senomyx, Inc. Molecules comprising linked organic moieties as flavor modifiers for comestibles compositions
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
ES2640453T3 (es) 2006-04-21 2017-11-03 Senomyx, Inc. Procesos para preparar composiciones saborizantes sólidas

Also Published As

Publication number Publication date
SG153714A1 (en) 2009-07-29
US20120201763A1 (en) 2012-08-09
US10557845B2 (en) 2020-02-11
JP2007517493A (ja) 2007-07-05
US20150064112A1 (en) 2015-03-05
US20050084506A1 (en) 2005-04-21
US20180364220A1 (en) 2018-12-20
WO2005041684A2 (en) 2005-05-12
PH12016501311B1 (en) 2017-06-05
NZ597500A (en) 2014-08-29
AU2004285410A1 (en) 2005-05-12
US20180003702A1 (en) 2018-01-04
JP5036310B2 (ja) 2012-09-26
PH12015501666A1 (en) 2018-06-11
PH12016501312A1 (en) 2017-06-05
US20150093339A1 (en) 2015-04-02
AU2004263871B2 (en) 2011-07-14
US11268952B2 (en) 2022-03-08
PH12015501664A1 (en) 2019-11-25
MXPA06001510A (es) 2006-09-04
PH12015501662B1 (en) 2018-04-30
US20070104709A1 (en) 2007-05-10
PH12015501667A1 (en) 2018-06-11
US8124121B2 (en) 2012-02-28
CA2900181C (en) 2019-01-29
AU2011201468A1 (en) 2011-04-21
US20200225217A1 (en) 2020-07-16
SG145745A1 (en) 2008-09-29
PH12015501667B1 (en) 2020-09-25
CA2535045A1 (en) 2005-02-17
US20110294981A1 (en) 2011-12-01
RU2419602C2 (ru) 2011-05-27
CL2016003325A1 (es) 2017-06-09
PH12015501662A1 (en) 2018-04-30
AR046078A1 (es) 2005-11-23
JP2008013570A (ja) 2008-01-24
CN103275058A (zh) 2013-09-04
US9091686B2 (en) 2015-07-28
ES2733577T3 (es) 2019-12-02
CL2004002015A1 (es) 2005-05-13
AU2011201468C9 (en) 2016-04-21
CA2535036C (en) 2015-11-24
US20200049699A1 (en) 2020-02-13
EP1660859A4 (en) 2012-10-10
IL207954A0 (en) 2010-12-30
EP3431464A3 (en) 2019-07-31
WO2005015158A9 (en) 2005-05-19
AU2011201468B2 (en) 2014-02-20
US8895050B2 (en) 2014-11-25
US10352929B2 (en) 2019-07-16
US20130336892A1 (en) 2013-12-19
PH12015501665A1 (en) 2021-09-01
PH12015501666B1 (en) 2018-06-11
JP2007330268A (ja) 2007-12-27
AU2004263871A1 (en) 2005-02-17
CA2535036A1 (en) 2005-05-12
PH12015501663A1 (en) 2018-06-25
US20080085994A1 (en) 2008-04-10
US7476399B2 (en) 2009-01-13
AU2004285410B2 (en) 2011-04-14
US8735081B2 (en) 2014-05-27
CA2900181A1 (en) 2005-05-12
WO2005041684A3 (en) 2009-04-09
NZ619746A (en) 2014-05-30
IL173551A0 (en) 2006-07-05
US20220326230A1 (en) 2022-10-13
WO2005015158A3 (en) 2007-01-04
PH12016501311A1 (en) 2017-06-05
EP1659881B1 (en) 2019-04-03
IL173552A (en) 2012-10-31
CN103275058B (zh) 2016-02-24
EP1660859A2 (en) 2006-05-31
MY174572A (en) 2020-04-27
US7888470B2 (en) 2011-02-15
US10060909B2 (en) 2018-08-28
NZ580418A (en) 2012-03-30
IL173551A (en) 2013-11-28
PH12015501663B1 (en) 2019-10-16
ZA200601904B (en) 2007-10-31
US8404455B2 (en) 2013-03-26
WO2005015158A2 (en) 2005-02-17
RU2006106919A (ru) 2007-09-20
JP5036446B2 (ja) 2012-09-26
RU2010112728A (ru) 2011-10-10
AU2011201468C1 (en) 2015-02-19
US20090111834A1 (en) 2009-04-30
NZ627505A (en) 2016-01-29
BRPI0413347A (pt) 2006-10-10
US20130030059A1 (en) 2013-01-31
NZ545747A (en) 2010-06-25
JP2007512227A (ja) 2007-05-17
IL173552A0 (en) 2006-07-05
RU2006106920A (ru) 2007-09-20
EP3431464A2 (en) 2019-01-23
US9459250B2 (en) 2016-10-04
EP1659881A2 (en) 2006-05-31
NZ545746A (en) 2012-03-30
EP1659881A4 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
BRPI0413324A (pt) receptores de paladar hetero-oligoméricos t1r, linhas de células que expressam os ditos receptores, e compostos de paladar
Liu et al. A smartphone-based dual detection mode device integrated with two lateral flow immunoassays for multiplex mycotoxins in cereals
Peters et al. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs
BR112022007593A2 (pt) Compostos indicadores, dispositivos que compreendem compostos indicadores e métodos de fabricação e uso dos mesmos
EP2215475A4 (en) IMMUNE TEST ANALYSIS PROCEDURE
EP2123754A4 (en) CHIMERIC FC RECEPTOR AND METHOD FOR DETERMINING ADCC ACTIVITY USING THE RECEPTOR
BR112016013353A2 (pt) Biossensor e método para produzir um biossensor
DE60137461D1 (de) Substituierte Piperidinverbindungen zur Verwendung als H3 Histaminerezeptorantagonisten
PL2013236T3 (pl) Przeciwciała łączące się z zewnątrzkomórkową domeną receptora kinazy tyrozynowej ALK
ATE479699T1 (de) Neue markierungsstrategien für den empfindlichen nachweis von analyten
Arkin et al. FLIPR™ Assays for GPCR and Ion Channel Targets
Fernández-Dueñas et al. Dopamine D2 receptor-mediated modulation of adenosine A2A receptor agonist binding within the A2AR/D2R oligomer framework
Khan et al. A simple and rapid fluorescence-based immunoassay for the detection of staphylococcal enterotoxin B
UA86946C2 (ru) Гетероолигомерные вкусовые рецепторы т1r, клеточные линии, которые экспресируют указанные рецепторы, и вкусовые соединения
ATE240522T1 (de) Chemilumineszenz-immunoassay zum nachweis eines mit der chagas-erkränkung verbundenen analyts in einer probe
BRPI0509516A (pt) método e aparelho para derivar um filtro de calibração, programa, transmissão de um programa, computador, método para processar dados eletromagnéticos usando um filtro de calibração, e, dados
DK1864131T3 (da) Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
BR112017017719A2 (pt) imunoensaio homogêneo com compensação para sinal antecedente
Wang et al. A recombinant estrogen receptor fragment-based homogeneous fluorescent assay for rapid detection of estrogens
Laycock et al. First report of a new rapid assay for diarrhetic shellfish poisoning toxins
Peng et al. Novel method for ANA quantitation using IIF imaging system
DE602004013280D1 (de) Screening-tests für cannabinoid-ligand-artige modulatoren von gpr55
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 22, 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.